Disclosure Information
Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.
Current Chairs
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Dr. Bhattacharya was awarded research grants, paid to her institution, from Gilead Sciences Inc.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Dr. Price was awarded research grants, paid to her institution, from Gilead Sciences Inc. and Merck & Co Inc. Spouse has interest in stock that is independently managed in AbbVie, Bristol-Myers Squibb, Johnson and Johnson, Merck.
Updated: 10/24/2022
Current Panel Members
Personal Financial Relationships: Dr. Feld serves as a scientific consultant to AbbVie, Antios, Arbutus, BluejayTherapeutics, Deep Genomics, Finch, Gilead, GSK, Janssen.
Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie, Alexion, Altimmune, Eiger, Enanta, Gilead, GSK, Janssen, Wako/Fujifilm.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: Dr. Jhaveri serves as a consultant for MedImmune/AstraZeneca,Seqirus and Dynavax. He also receives an editorial stipend from Elsevier.
Institutional Research: Dr. Jhaveri received research grants, paid to his institution, from AbbVie, Inc., and Gilead Sciences, Inc.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from Gilead Sciences, Inc.
Updated: 10/24/2022
Personal Financial Relationships:
Institutional Research:
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships:
Institutional Research:
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Inc., and Gilead Sciences, Inc.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: Dr. Terrault serves on the data safety monitoring board of Moderna(ceased as of April 2022).
Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from Gilead Sciences, GSK, Roche-Genentech, Helio Health
Updated: 10/24/2022
Personal Financial Relationships: Dr. Verna serves on an advisory board of Gilead Sciences, Inc.
Institutional Research: Dr. Verna was awarded research grants paid to her institution from Salix Pharmaceuticals.
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: None
Updated: 10/24/2022
Personal Financial Relationships: None
Institutional Research: Dr. Workowski was awarded research grants, paid to her institution, from Gilead Sciences, Inc.
Updated: 10/24/2022